Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Flavio STEINWURZ"'
Autor:
Flavio Steinwurz, Marta Brenner Machado, Guillermo Veitia, Juan Andres De Paula, Socrates Bautista Martinez, Beatriz Iade Vergara, Beatriz Capdevielle, Francisca Ana Martinez Silva, Ana Luz Ramirez
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: Inflammatory bowel diseases (IBDs) are chronic conditions that negatively interferes with the quality of life of the patients, on a physical, emotional, and social level. Its symptoms can vary including diarrhea, bleeding, abdominal pain,
Externí odkaz:
https://doaj.org/article/5139dfcb5be4425ea0937118a90b2485
Autor:
Scott D. Lee, Jessica R. Allegretti, Flavio Steinwurz, Susan B. Connelly, Nervin Lawendy, Jerome Paulissen, Krisztina B. Gecse
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Tofacitinib is an oral small molecule Janus kinase inhibitor for the treatment of ulcerative colitis. We evaluated tofacitinib efficacy and safety in the 52-week maintenance study, OCTAVE Sustain, by baseline Mayo endoscopic subsc
Externí odkaz:
https://doaj.org/article/9411950b9c8d41e883962ad33a442508
Autor:
Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Natália Sousa Freitas Queiroz, Aderson Omar Mourão Cintra Damião, Matheus Freitas Cardoso de Azevedo, Liliana Andrade Chebli, Erika Ruback Bertges, Antonio José Tiburcio Alves Junior, Orlando Ambrogini Junior, Bianca Loyo Pona Schiavetti da Silva, Marcio Lubini, Mauro Bafutto, Cristina Flores, Eduardo Garcia Vilela, Sandra Felice Boratto, Newton Luiz Tricarico Gasparetti Junior, Flavio Steinwurz, Nayara Salgado Carvalho, Omar Féres, José Joaquim Ribeiro da Rocha
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background The effectiveness of ustekinumab (UST) in the treatment of Crohn’s disease (CD) has been demonstrated in the pivotal Phase 3 UNITI 1 and 2 and IM-UNITI studies in both anti-TNF-naïve and anti-TNF-exposed patients. Given the sel
Externí odkaz:
https://doaj.org/article/1ae676670dde47428b23d064b72c8265
Autor:
Richard B. Gearry, Andrew M. McCombie, Morten Vatn, David T. Rubin, Flavio Steinwurz, Edward V. Loftus, Wolfgang Kruis, Curt Tysk, Jean-Frederic Colombel, Siew C. Ng, Gert Van Assche, Charles N. Bernstein
Publikováno v:
Inflammatory Intestinal Diseases, Pp 1-9 (2021)
Background and Aims: As inflammatory bowel disease (IBD) becomes more prevalent, the challenges that gastroenterologists face in managing these patients evolve. We aimed to describe the most important challenges facing gastroenterologists from around
Externí odkaz:
https://doaj.org/article/08e0986bcf6a49e4b3696e102164a819
Autor:
Stephan R. Vavricka, Thomas Greuter, Benjamin L. Cohen, Walter Reinisch, Flavio Steinwurz, Marc Fellmann, Xiang Guo, Nervin Lawendy, Jerome Paulissen, Laurent Peyrin-Biroulet
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). Here, we report steroid-free efficacy and safety with tofacitinib among patients with UC who received corticosteroids at baseline
Externí odkaz:
https://doaj.org/article/37c5068c68a84596aefa1ea91984fea2
Autor:
Eliane Aparecida Rosseto-Welter, Leticia D’argenio-Garcia, Filipa Blasco Tavares Pereira Lopes, Ana Eduarda Zulim Carvalho, Fernando Flaquer, Vanessa Severo-Lemos, Claudia Concer Viero Nora, Flavio Steinwurz, Lucas Pires Garcia Oliveria, Thiago Aloia, Luiz Vicente Rizzo, Cristóvão Luis Pitangueira Mangueira, Karina Inacio Carvalho
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2022 (2022)
Crohn’s disease (CD) is a chronic inflammatory disease with a complex interface of broad factors. There are two main treatments for Chron’s disease: biological therapy and nonbiological therapy. Biological agent therapy (e.g., anti-TNF) is the mo
Externí odkaz:
https://doaj.org/article/c02880b0ac524b9bb2c25993484305cd
Autor:
Paulo Gustavo Kotze, Flavio Steinwurz, Carlos Francisconi, Cyrla Zaltman, Marcia Pinheiro, Leonardo Salese, Dario Ponce de Leon
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 13 (2020)
The incidence and prevalence of ulcerative colitis (UC) has been reported to be rising in newly industrialised regions, such as Latin America. Here, we review data from published studies reporting demographics and clinical aspects of UC in Latin Amer
Externí odkaz:
https://doaj.org/article/e27f593f7b9b45e3aad6c2ad4599ae2c
Autor:
Flavio Steinwurz, Andrea Vieira, Nayara Salgado Carvalho, Fernando Seefelder Flaquer, Fernanda Bellotti Formiga
Publikováno v:
Journal of Coloproctology, Vol 37, Iss , Pp 110- (2017)
Externí odkaz:
https://doaj.org/article/6cc358b79f9a48328138326b9531d2d7
Autor:
Flavio Steinwurz
Publikováno v:
Arquivos de Gastroenterologia, Vol 40, Iss 3, Pp 198-200 (2003)
RACIONAL - OBJETIVO: Avaliar a eficácia do infliximab no tratamento de pacientes com doença de Crohn ativa ou com fístulas. MÉTODOS: Quarenta e quatro portadores de doença de Crohn, refratários ao tratamento convencional, foram tratados com inf
Externí odkaz:
https://doaj.org/article/45067f0352314356b84b7e9c329a8b1d
Autor:
Flavio STEINWURZ
Publikováno v:
Arquivos de Gastroenterologia, Vol 36, Iss 4, Pp 207-209 (1999)
Foram estudados 16 pacientes portadores de doença de Crohn com fístulas. A evolução de 29 fístulas, nestes casos, 10 tratadas por cirurgia e 19 através de medicamentos, foi acompanhada quanto à cicatrização e melhora do processo.Sixteen Croh
Externí odkaz:
https://doaj.org/article/1a304433a2de45bfb1c3e34fce944cdf